Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03860818 · ClinicalTrials.gov registry record · NA
Improving Transplant Medication Safety Through A Technology and Pharmacist Intervention
A NA study, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- NA
- Development phase
- 2,196
- Enrollment target
NCT03860818: Completed NA study, sponsored by VA Office of Research and Development.
NCT03860818 is a NA study that has completed, run by VA Office of Research and Development. The registered enrollment target is 2,196 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03860818, a NA study, has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- NA
- Development phase
- 2,196 participants
- Enrollment target
Study Summary
Medication safety issues in Veteran organ transplant recipients, including side effects and errors, are a major issue leading to graft failure and death. The causes of these events are complicated and involve fragmented care, communication breakdowns between the Veterans, providers and the different health care systems. This grant proposal seeks to improve medication safety within these high-risk Veterans, using two innovative components; the application of technology to leverage the massive amount of data contained within the electronic medical record in identifying Veterans with potential medication safety issues, coupled with a pharmacist-led intervention to improve the management and coordination of immunosuppression therapy. The completion of this prospective, multicenter, cluster randomized controlled clinical trial will provide evidence that these interventions can improve medication safety, clinical outcomes and costs and will be used to justify the dissemination of these interventions to all VAs caring for Veteran transplant recipients across the U.S.
Interventions
- OTHER Health services delivery
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,196 participants |
| Start Date | 2019-03-18 |
| Est. Completion | 2021-06-14 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03860818
The ClinicalTrials.gov registry entry for NCT03860818 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 2,196 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Health services delivery is the first listed.
NCT03860818 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03860818 about?
NCT03860818 is a clinical study titled "Improving Transplant Medication Safety Through A Technology and Pharmacist Intervention". Medication safety issues in Veteran organ transplant recipients, including side effects and errors, are a major issue leading to graft failure and death. The causes of these events are complicated and involve fragmented care, communication breakdowns between the Veterans, providers and the different...
What is the current status of trial NCT03860818?
This trial is currently completed. It is a NA study. The enrollment target is 2,196 participants. The study started on 2019-03-18. Estimated completion is 2021-06-14.
What interventions are being tested in trial NCT03860818?
The interventions under investigation include: Health services delivery (OTHER).
Who is sponsoring clinical trial NCT03860818?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.